Drug Patents owned by Swedish Orphan

1. List of Orfadin drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9301932 SWEDISH ORPHAN Liquid pharmaceutical composition comprising nitisinone
Feb, 2033

(10 years from now)

Drugs and Companies using NITISINONE ingredient

Market Authorisation Date: 22 April, 2016

Treatment: Treatment of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine

Dosage: SUSPENSION;ORAL

More Information on Dosage

ORFADIN family patents

3

United States

2

Sweden

1

RS

1

Brazil

1

Australia

1

Chile

1

Poland

1

Ukraine

1

Spain

1

Israel

1

Cyprus

1

Mexico

1

Japan

1

Slovenia

1

Hungary

1

Russia

1

Croatia

1

China

1

San Marino

1

Canada

1

New Zealand

1

Denmark

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in